DINESH

Acutaas Chemicals

3,568 ▲ 1.17% 01-Jul-2026
Buy
Upside: 9.8%
Horizon: 2 Years

Stock Snapshot

Current Price
3,568
1 Year Target Price
3,562
2 Year Target Price
4,303
52 Week High / Low
3,568 / 1,095
20 Day Return
+12.7%
Market Cap (Cr.)
28,844
Current PE
70.4
P/BV Ratio
17.5
Dividend Yield
0.2%
Industry PE
36.1

Price Performance

Recommendation Rationale

Strong growth outlook supported by strategic expansions and a solid product pipeline.

Basis of our Recommendation

Acutaas Chemicals is poised for robust growth driven by strategic expansions into high-value sectors such as battery and semiconductor chemicals. The company is leveraging significant investments in R&D and capacity expansion, with a strong pipeline of new products and long-term customer contracts. However, it faces operational challenges related to global supply chain disruptions and execution risks associated with large-scale projects.

AI Generated Summary - Coming Soon!

👍 Why We Like This Stock

  • Strategic entry into high-growth sectors like battery and semiconductor chemicals
  • Strong revenue growth forecast of 25% for FY27 backed by long-term contracts
  • Significant investments in R&D and capacity expansion to support future growth

Things To Watch Out For

  • Operational challenges due to global supply chain disruptions
  • Execution risks related to large-scale capital expenditures and new market entries

Key Parameters

Balance Sheet Strength
Conservatively Financed
Market Share Trend
Stable
Industry Lifecycle
Expanding
Analyst Coverage
Moderate
Dividend History
Regular
FII Holdings
Increasing

Financial Snapshot

Actuals Forecast
FY24 FY25 FY26 FY27 FY28
Revenue (Cr.) 717 1,007 1,339 1,651 2,000
Profit Before Tax (Cr.) 114 216 483 572 696
PBT Margin 15.9% 21.4% 36.1% 34.6% 34.8%
Net Profit (Cr.) 72 167 365 434 528
EPS 8.1 20.1 44.6 53.1 64.6

Company Overview

Show Company Profile

Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications. It also provides specialty chemicals for use in battery chemicals, personal care, agrochemicals, coatings, electronics, and industrial processes; photoresist chemicals to semiconductor applications; electrolyte additives for lithium battery cells; and parabens, methyl salicylate, and other commodity chemicals for cosmetics, agrochemicals, and fine chemicals. The company was formerly known as Ami Organics Limited and changed its name to Acutaas Chemicals Limited in May 2025. Acutaas Chemicals Limited was founded in 2004 and is based in Surat, India.